# Alopecia trials recruiting, no drug phase: 35 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 35 trials with no drug phase for alopecia that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting alopecia trials with no drug phase: 35 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/not-applicable/alopecia

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 35
- Recruiting or not yet: 35
- Read on: November 19, 2026

## Trials

The 25 newest of 35, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 13, 2026 | NCT07935993 | Scalp Serum Paired With HydraFacial HydraScalp Keravive™ Treatment in Patients With Self-Perceived Hair Thinning | Revision Skincare | Not applicable | Not yet recruiting | Hair Loss, Hair Thinning | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07935993) |
| November 10, 2026 | NCT07929857 | Effectiveness and Safety of Cellbooster Hair in Healthy Subjects | Suisselle | Not applicable | Not yet recruiting | Hair and Scalp Health | 55 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07929857) |
| November 5, 2026 | NCT07919782 | Study to Evaluate Xtressé Gummy Supplement in Women With Thinning Hair | Restore Biologics Holdings, Inc. dba Xtressé | Not applicable | Not yet recruiting | Androgenetic Alopecia | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919782) |
| October 28, 2026 | NCT07901062 | Clinical Study to Evaluate the Impact of Nutraceutical Supplements in Participants With Self-Perceived Thinning Hair | Unilever R&D | Not applicable | Not yet recruiting | Hair Thinning | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07901062) |
| September 30, 2026 | NCT07850011 | Evidence-Based Integrated Protocol to Maximize Hair Follicle Survival in Follicular Unit Extraction (FUE) | Assiut University | Not applicable | Not yet recruiting | Androgenetic Alopecia, Cicatricial Alopecia | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07850011) |
| September 9, 2026 | NCT07810504 | Dual Modality Treatment of Androgenic Alopecia With KeraFactor® Solution and Revian® LED Light Therapy | K. Kay Durairaj, MD, FACS, A Medical Corporation | Not applicable | Recruiting | Androgenic Alopecia, Female Pattern Hair Loss, Hair Loss | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07810504) |
| September 9, 2026 | NCT07809191 | Hair Regrowth Following Partial Thickness Removal of SSCIS | Cooper Norcross Health | Not applicable | Not yet recruiting | Squamous Cell Carcinoma (Skin), Squamous Cell Carcinoma in Situ, Alopecia | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07809191) |
| September 8, 2026 | NCT07806474 | Efficacy and Safety of Two Hair Supplements in Men With Androgenic Alopecia | Activ'inside | Not applicable | Recruiting | Androgenic Alopecia, Healthy Adult Male | 99 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07806474) |
| August 24, 2026 | NCT07783113 | Dietary Supplement for Telogen Effluvium Associated With GLP-1 Receptor Agonist Use | Farmoquimica S.A. | Not applicable | Not yet recruiting | Alopecia | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07783113) |
| August 11, 2026 | NCT07758400 | A Study on the Efficacy and Safety of Microneedling for Male Androgenetic Alopecia | Sponsor not shown (see the record) | Not applicable | Not yet recruiting | Androgenetic Alopecia | 190 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07758400) |
| May 1, 2026 | NCT07563036 | JAK2 Expression in Androgenetic Alopecia Before and After Topical Minoxidil | Kasr El Aini Hospital | Not applicable | Recruiting | Androgenetic Alopecia, Androgenic Alopecia | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07563036) |
| April 17, 2026 | NCT07536100 | VENEZE Peptide Factor Hair Serum Compared With Topical 2% Minoxidil for Androgenetic Alopecia | Institute of Dermatology, Thailand | Not applicable | Recruiting | Androgenetic Alopecia (AGA) | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07536100) |
| March 31, 2026 | NCT07502976 | Topical 2-Deoxy-D-ribose Hydrogel Versus Minoxidil 5% Solution for Androgenetic Alopecia | Kasr El Aini Hospital | Not applicable | Recruiting | Androgenic Alopecia | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07502976) |
| February 20, 2026 | NCT07422376 | Evaluation of Scalp Cooling During Chemotherapy on Quality of Life and the Potential Role of Single Nucleotide Variations on... | Sponsor not shown (see the record) | Not applicable | Recruiting | Alopecia | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07422376) |
| December 17, 2025 | NCT07287579 | Comparison Between Platelet Rich Plasma and Nanofat as an Adjuvant Therapy in HairTransplantation | Sohag University | Not applicable | Not yet recruiting | Androgenic Alopecia | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07287579) |
| November 25, 2025 | NCT07248410 | A Split-Scalp Study Evaluating the Efficacy and Safety of Fractional Laser Therapy With and Without Exosomes in the Treatment of... | Chang Gung Memorial Hospital | Not applicable | Recruiting | Androgenetic Alopecia | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07248410) |
| August 6, 2025 | NCT07107841 | Autologous Hair Follicle Secretome for Androgenic Alopecia (Single Site) | Acorn Biolabs Inc. | Not applicable | Recruiting | Androgenic Alopecia, Alopecia, Baldness | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07107841) |
| July 23, 2025 | NCT07079657 | Thulium Laser and Growth Factors for Androgenetic Alopecia | Universitätsklinikum Hamburg-Eppendorf | Not applicable | Recruiting | Androgenetic Alopecia (AGA) | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07079657) |
| July 9, 2025 | NCT07056933 | Effect of Minoxidil Solution Iontophoresis on Androgenic Alopecia | Cairo University | Not applicable | Not yet recruiting | Alopecia | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07056933) |
| June 27, 2025 | NCT07041489 | Evaluating the Combined Use of Supplement and Serum in Promoting Hair Growth in Women With Self-perceived Thinning Hair | The Center for Clinical and Cosmetic Research | Not applicable | Recruiting | Hair Thinning | 85 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07041489) |
| June 12, 2025 | NCT07018349 | Low Dose Oral Minoxdil in Androgenic Alopecia | Jinnah Postgraduate Medical Centre | Not applicable | Not yet recruiting | Androgenetic Alopecia (AGA) | 76 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07018349) |
| May 31, 2025 | NCT06998680 | 6-Month Trial of Chinese Herbal Treatments for Hair Loss and Gray Hair | Vita Green Pharmaceutical (H.K.) Ltd. | Not applicable | Recruiting | Alopecia, Canities | 152 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06998680) |
| May 2, 2025 | NCT06955702 | Effect of Cryotherapy in the Prevention of Madarosis Produced by Chemotherapy in Breast Cancer Patients | University of Salamanca | Not applicable | Recruiting | Breast Neoplasms, Alopecia, Madarosis, Eyebrow Diseases, Eyelash Diseases, Anthracyclines, Taxoids, Side Effects | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06955702) |
| April 27, 2025 | NCT06946550 | Non-Ablative Laser to Treat Scarring Alopecia With Hair Follicle Gene Expression Analysis | Montefiore Medical Center | Not applicable | Recruiting | Scarring Alopecia | 5 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06946550) |
| April 13, 2025 | NCT06926023 | 1550nm Non-ablative Fractional Vs 1927nm Thulium Fractional Laser for the Treatment of Female Pattern Hair Loss | Sponsor not shown (see the record) | Not applicable | Not yet recruiting | Female Pattern Baldness | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06926023) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Montefiore Medical Center | 3 |
| Kasr El Aini Hospital | 2 |
| Sohag University | 1 |
| Universitätsklinikum Hamburg-Eppendorf | 1 |
| Cooler Heads Care Inc. | 1 |
| Chang Gung Memorial Hospital | 1 |
| The Center for Clinical and Cosmetic Research | 1 |
| Assiut University | 1 |
| Acorn Biolabs Inc. | 1 |
| [Lumenis Be Ltd.](https://specstream.ai/data/clinical-trials/company/lumenis-be-ltd) | 1 |
| Institute of Dermatology, Thailand | 1 |
| [Unilever R&D](https://specstream.ai/data/clinical-trials/company/unilever-r-and-d) | 1 |
| University of Salamanca | 1 |
| [Revision Skincare](https://specstream.ai/data/clinical-trials/company/revision-skincare) | 1 |
| Farmoquimica S.A. | 1 |
| Activ'inside | 1 |
| Jinnah Postgraduate Medical Centre | 1 |
| K. Kay Durairaj, MD, FACS, A Medical Corporation | 1 |
| Children's Hospital Los Angeles | 1 |
| St. Jude Children's Research Hospital | 1 |
| Chinese University of Hong Kong | 1 |
| [Venus Concept](https://specstream.ai/data/clinical-trials/company/venus-concept) | 1 |
| Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital | 1 |
| Suisselle | 1 |
| Cairo University | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 15 |
| Egypt | 3 |
| Spain | 2 |
| China | 2 |
| Germany | 1 |
| Taiwan | 1 |
| Thailand | 1 |
| Brazil | 1 |
| Italy | 1 |
| Pakistan | 1 |
| Hong Kong | 1 |
| Turkey (Türkiye) | 1 |
| France | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Brazilian restaurants in the United States](https://specstream.ai/data/businesses/brazilian-restaurants/united-states)
- [Freight and cargo companies in the United States](https://specstream.ai/data/businesses/freight-and-cargo-companies/united-states)
- [Orthodontics practices in the United States](https://specstream.ai/data/businesses/orthodontics-practices/united-states)
- [Traffic ticketing law firms in the United States](https://specstream.ai/data/businesses/traffic-ticketing-law-firms/united-states)
- [Cafes in the United States](https://specstream.ai/data/businesses/cafes/united-states)
- [Gluten free restaurants in the United States](https://specstream.ai/data/businesses/gluten-free-restaurants/united-states)
